Jefferies Adjusts Astellas Pharma's Price Target to 2,100 Yen From 2,200 Yen, Keeps at Buy
MT NewswiresApr 3 16:42
Jefferies Adjusts Astellas Pharma's Price Target to 2,200 Yen From 2,400 Yen, Keeps at Buy
MT NewswiresDec 18, 2023 18:12
Jefferies Upgrades Astellas Pharma to Buy From Hold, Keeps Price Target at 2,400 Yen
MT NewswiresOct 24, 2023 17:23
Jefferies Adjusts Astellas Pharma's Price Target to 2,400 Yen From 2,300 Yen, Keeps at Buy
MT NewswiresMay 2, 2023 18:13
Taysha Downgraded at Jefferies Citing Uncertain Outlook for Lead Asset
Seeking AlphaFeb 2, 2023 02:03
Taysha Gene Therapies Downgraded to Neutral at Goldman Sachs on Measured Outlook
Seeking AlphaNov 10, 2022 00:57
No Data
No Data